Wedbush Morgan downgrades United Therapeutics Corp. (Nasdaq: UTHR) from Outperform to Neutral after FDA approval of Tyvaso, as expected. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE